Spherix Global Insights
Spherix Global Insights Spherix Global Insights is a newly established business intelligence and market research company with US offices in both Malvern, PA and Cambridge, MA, and a European office in Zug, Switzerland. Our approach is to apply our commercial experience and unique relationships within core specialty markets to translate data into insight, enabling our clients to make smarter business decisions.
-
-
-
-
-
-
-
Alzheimer's drug adoption in US slowed by doctors' skepticism
-
-
-
-
-
-
-
Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
-
-
-
-
-
-
-
Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilization of IL-17 Inhibitors
-
-
-
-
-
-
-
U.S. Neurologists Eagerly Await Promising Oral Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement
-
-
-
-
-
-
-
US Gastroenterologist Projections Suggest Significant Shift in Ulcerative Colitis Landscape Afoot, with Launches of Eli Lilly's Omvoh, Pfizer's Velsipity, Takeda's Subcutaneous Entyvio,
-
-
-
-
-
-
-
Consecutive Use of TNF-Inhibitors for the Treatment of Psoriatic Arthritis at Lowest Point Recorded, as Use of Biologics with Alternate Mechanisms of Actions Continue to Grow, According to Spherix Glo
-
-
-
-
-
-
-
What’s on Your Must-Read List? If You Work in Pharma, Add Spherix Global Insights’ Generalized Myasthenia Gravis Patient Chart Audit to that List
-
537 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All
